Related Experiment Video
Updated: Nov 10, 2025

09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
34.3K
Partial Lipodystrophy and LMNA p.R545H Variant
Silvia Magno1, Giovanni Ceccarini1, Andrea Barison2,3
1Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa, 56124 Pisa, Italy.
Journal of Clinical Medicine
|April 3, 2021
Summary
Mutations in the LMNA gene cause laminopathies. The LMNA p.R545H variant shows variable expressivity and incomplete penetrance, suggesting other factors influence disease presentation.
Area of Science:
- Genetics
- Molecular Biology
- Medical Science
Background:
- Laminopathies arise from mutations in the LMNA gene, leading to diverse clinical presentations.
- The precise mechanisms driving tissue specificity and varied clinical outcomes in laminopathies remain unclear.
Purpose of the Study:
- To investigate the clinical and molecular characteristics of a patient with a heterozygous LMNA c.1634G>A (p.R545H) variant.
- To explore the variable expressivity and incomplete penetrance associated with the LMNA p.R545H variant.
Main Methods:
- Case study of a patient with suspected lipodystrophy and a heterozygous LMNA p.R545H variant.
- In silico analysis of the p.R545H amino acid substitution.
- Review of clinical data from other patients with the LMNA p.R545H allele.
Main Results:
- The patient presented with mild, transient myopathy and abnormal subcutaneous fat distribution, mimicking familial partial lipodystrophy type 2.
- The LMNA p.R545H variant, found at low frequency, is predicted to be damaging by in silico analysis.
- Other patients with the p.R545H allele exhibited significant heterogeneity in body fat distribution and organ involvement.
Conclusions:
- The heterozygous LMNA p.R545H variant displays incomplete penetrance and highly variable expressivity.
- Additional genetic, epigenetic, or environmental factors likely contribute to the phenotypic variability observed in patients with this variant.
Related Concept Videos
Overview of Lipid Metabolism
3.6K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
3.6K
Lysosomal Hydrolases
4.2K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.2K
Lipid Catabolism
466
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
466

